ICRF-159 PLUS RADIATION VERSUS RADIATION-THERAPY ALONE IN CERVICAL-CARCINOMA - A DOUBLE-BLIND-STUDY

被引：4

作者：

BELLONI, C

MANGIONI, C

BORTOLOZZI, G

CARINELLI, S

DINCALCI, M

MAGGIONI, A

MORASCA, L

机构：

[1] IST CLIN PERFEZIONAMENTO,ANAT ISTOL PATOL LAB,MILANO,ITALY

[2] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY

来源：

ONCOLOGY | 1983年 / 40卷 / 03期

关键词：

D O I：

10.1159/000225721

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：181 / 185

页数：5

共 23 条

[1] DOUBLE-BLIND CONTROLLED CLINICAL-TRIAL OF RADIATION PLUS RAZOXANE (ICRF-159) VERSUS RADIATION PLUS PLACEBO IN TREATMENT OF HEAD AND NECK CANCER [J].

BAKOWSKI, MT ;

MACDONALD, E ;

MOULD, RF ;

CAWTE, P ;

SLOGGEM, J ;

BARRETT, A ;

DALLEY, V ;

NEWTON, KA ;

WESTBURY, G ;

JAMES, SE ;

HELLMANN, K .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (1-2) :115-119

[2] CLINICAL EVALUATION OF ICRF-159 AS A RADIOSENSITIZING AGENT [J].

BATES, T .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (1-2) :127-131

[3] EXTRAPELVIC LYMPH-NODE METASTASES IN CERVICAL-CARCINOMA [J].

BUCHSBAUM, HJ .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 133 (07) :814-824

[4]

CASSADY JR, 1975, CANCER, V36, P946, DOI 10.1002/1097-0142(197509)36:3<946::AID-CNCR2820360316>3.0.CO

[5]

2-5

[6]

CREAVEN PJ, 1974, CANCER CHEMOTH REP 1, V58, P393

[7]

DANGIO GJ, 1962, AMER J ROENTGENOL RA, V87, P106

[8]

DISCHE S, 1978, BRIT J CANCER, V37, P311

[9] ANALYSIS OF CENTRAL RECURRENT DISEASE IN STAGES-1 AND STAGES-2 SQUAMOUS CELL CARCINOMAS OF CERVIX ON INTACT UTERUS [J].

DURRANCE, FY ;

FLETCHER, GH ;

RUTLEDGE, FN .

AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1969, 106 (04) :831-&

[10]

HASSENSTEIN E, 1977, MED KLIN, V72, P171

← 1 2 3 →